Acyclovir

阿昔洛韦

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameAcyclovir
Drug Alias Name阿昔洛维AcycloguanosineAciclovirum阿昔诺韦Aciclovir +[15] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsPlantar WartUlcerMeniere Disease +[15] 
Global Approved IndicationsHerpes ZosterVaricella Zoster Virus InfectionHerpes Labialis +[5] 
Approved Indications in ChinaHerpes ZosterVaricella Zoster Virus Infection
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCzechiaCanadaBotswana +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesINTERNATIONAL BIO SERVICES CO LTDGlaxosmithkline PlcCairo University +[5] 
Inactive CompaniesInstitute For The Development Of AfricaPharmobedient Consulting LLCNational Institute for Communicable Diseases +[18] 
Active IndicationsPlantar WartHerpes ZosterVaricella Zoster Virus Infection +[6] 
Inactive IndicationsUlcerMeniere DiseaseChickenpox +[9] 

Other Information

ATC CodeD06BB03J05AB01S01AD03
Related LinksWikipediaDrugBankKEGG